Lymphadenectomy in Urologic Oncology: Pathologic Considerations

Riley E. Alexander, Ming Tse Sung, Liang Cheng

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Lymphadenectomy (LAD) is an important staging and treatment modality of oncologic surgery. LAD in genitourinary malignancies presents inherent difficulties to the urologist and pathologist because of the differences in anatomic sites and primary histologic type. This review focuses on pathologic evaluation and how communication between urologist and pathologist is necessary to provide optimal care. Recommendations covering general specimen submission and processing are discussed, as well as more specific recommendations concerning the kidney, upper urinary tract, urinary bladder, prostate, testes, and penis. Emerging areas of prognostic significance and the impact that improved molecular techniques are contributing to diagnostic interpretation are highlighted.

Original languageEnglish (US)
Pages (from-to)483-495
Number of pages13
JournalUrologic Clinics of North America
Volume38
Issue number4
DOIs
StatePublished - Nov 1 2011

Fingerprint

Lymph Node Excision
Penis
Urinary Tract
Testis
Prostate
Urinary Bladder
Communication
Kidney
Neoplasms
Urologists
Pathologists
Therapeutics

Keywords

  • Lymphadenectomy
  • Sampling and reporting
  • Staging and classification
  • Urinary bladder
  • Urothelial cancer

ASJC Scopus subject areas

  • Urology

Cite this

Lymphadenectomy in Urologic Oncology : Pathologic Considerations. / Alexander, Riley E.; Sung, Ming Tse; Cheng, Liang.

In: Urologic Clinics of North America, Vol. 38, No. 4, 01.11.2011, p. 483-495.

Research output: Contribution to journalReview article

Alexander, Riley E. ; Sung, Ming Tse ; Cheng, Liang. / Lymphadenectomy in Urologic Oncology : Pathologic Considerations. In: Urologic Clinics of North America. 2011 ; Vol. 38, No. 4. pp. 483-495.
@article{fdfc07f76b0446ba988f6af238695342,
title = "Lymphadenectomy in Urologic Oncology: Pathologic Considerations",
abstract = "Lymphadenectomy (LAD) is an important staging and treatment modality of oncologic surgery. LAD in genitourinary malignancies presents inherent difficulties to the urologist and pathologist because of the differences in anatomic sites and primary histologic type. This review focuses on pathologic evaluation and how communication between urologist and pathologist is necessary to provide optimal care. Recommendations covering general specimen submission and processing are discussed, as well as more specific recommendations concerning the kidney, upper urinary tract, urinary bladder, prostate, testes, and penis. Emerging areas of prognostic significance and the impact that improved molecular techniques are contributing to diagnostic interpretation are highlighted.",
keywords = "Lymphadenectomy, Sampling and reporting, Staging and classification, Urinary bladder, Urothelial cancer",
author = "Alexander, {Riley E.} and Sung, {Ming Tse} and Liang Cheng",
year = "2011",
month = "11",
day = "1",
doi = "10.1016/j.ucl.2011.07.001",
language = "English (US)",
volume = "38",
pages = "483--495",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Lymphadenectomy in Urologic Oncology

T2 - Pathologic Considerations

AU - Alexander, Riley E.

AU - Sung, Ming Tse

AU - Cheng, Liang

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Lymphadenectomy (LAD) is an important staging and treatment modality of oncologic surgery. LAD in genitourinary malignancies presents inherent difficulties to the urologist and pathologist because of the differences in anatomic sites and primary histologic type. This review focuses on pathologic evaluation and how communication between urologist and pathologist is necessary to provide optimal care. Recommendations covering general specimen submission and processing are discussed, as well as more specific recommendations concerning the kidney, upper urinary tract, urinary bladder, prostate, testes, and penis. Emerging areas of prognostic significance and the impact that improved molecular techniques are contributing to diagnostic interpretation are highlighted.

AB - Lymphadenectomy (LAD) is an important staging and treatment modality of oncologic surgery. LAD in genitourinary malignancies presents inherent difficulties to the urologist and pathologist because of the differences in anatomic sites and primary histologic type. This review focuses on pathologic evaluation and how communication between urologist and pathologist is necessary to provide optimal care. Recommendations covering general specimen submission and processing are discussed, as well as more specific recommendations concerning the kidney, upper urinary tract, urinary bladder, prostate, testes, and penis. Emerging areas of prognostic significance and the impact that improved molecular techniques are contributing to diagnostic interpretation are highlighted.

KW - Lymphadenectomy

KW - Sampling and reporting

KW - Staging and classification

KW - Urinary bladder

KW - Urothelial cancer

UR - http://www.scopus.com/inward/record.url?scp=80955159727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80955159727&partnerID=8YFLogxK

U2 - 10.1016/j.ucl.2011.07.001

DO - 10.1016/j.ucl.2011.07.001

M3 - Review article

C2 - 22045179

AN - SCOPUS:80955159727

VL - 38

SP - 483

EP - 495

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 4

ER -